miRNAs在骨髓间充质干细胞成骨分化中的作用
The Role of miRNAs in the Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells
DOI: 10.12677/jcpm.2025.41051, PDF,   
作者: 夏振然*, 肖 军, 郭天琦, 常志强#:内蒙古医科大学第二附属医院创伤中心,内蒙古 呼和浩特
关键词: 骨髓间充质干细胞成骨分化信号通路miRNAsBone Marrow Mesenchymal Stem Cells Osteogenic Differentiation Signaling Pathways miRNAs
摘要: 间充质干细胞(MSC),也称为多能基质细胞,是一种首次在骨髓中发现的非造血干细胞群,目前已从各种成体组织来源中分离出来,是能够分化为多种间充质组织(如脂肪和骨骼)的成熟细胞的多能细胞。MicroRNAs (miRNA)是一种高度保守的内源性非蛋白质编码RNA,通过翻译抑制或降解其靶标来调节基因表达,在调节BMSC分化中起主要作用。本文探讨了miRNAs骨髓间充质干细胞成骨分化中的作用。
Abstract: Mesenchymal stem cells (MSCs), also known as pluripotent stromal cells, are a population of non-hematopoietic stem cells first discovered in the bone marrow that have been isolated from various adult tissue sources and are pluripotent cells capable of differentiating into mature cells of a variety of mesenchymal tissues, such as fat and bone. MicroRNAs (miRNAs) are highly conserved endogenous non-protein-coding RNAs that play a major role in regulating BMSC differentiation by translating inhibition or degradation of their targets to regulate gene expression. This article explores the role of miRNAs in osteogenic differentiation of bone marrow mesenchymal stem cells.
文章引用:夏振然, 肖军, 郭天琦, 常志强. miRNAs在骨髓间充质干细胞成骨分化中的作用[J]. 临床个性化医学, 2025, 4(1): 334-340. https://doi.org/10.12677/jcpm.2025.41051

参考文献

[1] Teitelbaum, S.L. (2000) Bone Resorption by Osteoclasts. Science, 289, 1504-1508. [Google Scholar] [CrossRef] [PubMed]
[2] Friedenstein, A.J., Chailakhyan, R.K. and Gerasimov, U.V. (1987) Bone Marrow Osteogenic Stem Cells: In Vitro Cultivation and Transplantation in Diffusion Chambers. Cell Proliferation, 20, 263-272. [Google Scholar] [CrossRef] [PubMed]
[3] Beyer, C., Zampetaki, A., Lin, N., Kleyer, A., Perricone, C., Iagnocco, A., et al. (2015) Signature of Circulating MicroRNAs in Osteoarthritis. Annals of the Rheumatic Diseases, 74, e18. [Google Scholar] [CrossRef] [PubMed]
[4] Jackson, R.J. and Standart, N. (2007) How Do MicroRNAs Regulate Gene Expression? Sciences STKE, 2007, re1. [Google Scholar] [CrossRef] [PubMed]
[5] Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. Elegans Heterochronic Gene Lin-4 Encodes Small RNAs with Antisense Complementarity to Lin-14. Cell, 75, 843-854. [Google Scholar] [CrossRef] [PubMed]
[6] Farh, K.K., Grimson, A., Jan, C., Lewis, B.P., Johnston, W.K., Lim, L.P., et al. (2005) The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution. Science, 310, 1817-1821. [Google Scholar] [CrossRef] [PubMed]
[7] Huntzinger, E. and Izaurralde, E. (2011) Gene Silencing by MicroRNAs: Contributions of Translational Repression and mRNA Decay. Nature Reviews Genetics, 12, 99-110. [Google Scholar] [CrossRef] [PubMed]
[8] Mizuno, Y., Yagi, K., Tokuzawa, Y., Kanesaki-Yatsuka, Y., Suda, T., Katagiri, T., et al. (2008) miR-125b Inhibits Osteoblastic Differentiation by Down-Regulation of Cell Proliferation. Biochemical and Biophysical Research Communications, 368, 267-272. [Google Scholar] [CrossRef] [PubMed]
[9] Zhou, B., Peng, K., Wang, G., Chen, W., Liu, P., Chen, F., et al. (2020) miR-483-3p Promotes the Osteogenesis of Human Osteoblasts by Targeting Dikkopf 2 (DKK2) and the Wnt Signaling Pathway. International Journal of Molecular Medicine, 46, 1571-1581. [Google Scholar] [CrossRef] [PubMed]
[10] Huang, Y., Xiao, D., Huang, S., Zhuang, J., Zheng, X., Chang, Y., et al. (2020) Circular RNA YAP1 Attenuates Osteoporosis through Up-Regulation of YAP1 and Activation of Wnt/β-Catenin Pathway. Biomedicine & Pharmacotherapy, 129, Article 110365. [Google Scholar] [CrossRef] [PubMed]
[11] Huang, Y., Xu, Y., Feng, S., He, P., Sheng, B. and Ni, J. (2021) miR-19b Enhances Osteogenic Differentiation of Mesenchymal Stem Cells and Promotes Fracture Healing through the WWP1/Smurf2-Mediated KLF5/β-Catenin Signaling Pathway. Experimental & Molecular Medicine, 53, 973-985. [Google Scholar] [CrossRef] [PubMed]
[12] Feng, Y., Wan, P., Yin, L. and Lou, X. (2020) The Inhibition of MicroRNA-139-5p Promoted Osteoporosis of Bone Marrow-Derived Mesenchymal Stem Cells by Targeting Wnt/Beta-Catenin Signaling Pathway by NOTCH1. Journal of Microbiology and Biotechnology, 30, 448-458. [Google Scholar] [CrossRef] [PubMed]
[13] Li, Z., Hu, H., Zhang, X., Liu, G., Ran, B., Zhang, P., et al. (2019) miR‐291a‐3p Regulates the BMSCs Differentiation via Targeting DKK1 in Dexamethasone‐Induced Osteoporosis. The Kaohsiung Journal of Medical Sciences, 36, 35-42. [Google Scholar] [CrossRef] [PubMed]
[14] Lamplot, J.D., Qin, J., Nan, G., et al. (2013) BMP9 Signaling in Stem Cell Differentiation and Osteogenesis. American Journal of Stem Cells, 2, 1-21.
[15] Chen, G., Deng, C. and Li, Y. (2012) TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation. International Journal of Biological Sciences, 8, 272-288. [Google Scholar] [CrossRef] [PubMed]
[16] Sun, M.H., Wang, W.J., Li, Q., et al. (2018) Autologous Oxygen Release Nano Bionic Scaffold Composite miR-106a Induced BMSCs Enhances Osteoblast Conversion and Promotes Bone Repair through Regulating BMP-2. European Review for Medical and Pharmacological Sciences, 22, 7148-7155.
[17] 陈伟娜, 王亮, 陈立叶. 血清miR-125a-3p、BMP-2水平与骨质疏松性椎体压缩性骨折术后延迟愈合的关系[J]. 山东医药, 2023, 63(25): 56-59.
[18] Zeng, H., Dong, L., Huang, Y., Xu, C., Zhao, X. and Wu, L. (2021) USF2 Reduces BMP3 Expression via Transcriptional Activation of miR-34a, Thus Promoting Osteogenic Differentiation of BMSCs. Journal of Bone and Mineral Metabolism, 39, 997-1008. [Google Scholar] [CrossRef] [PubMed]
[19] Qi, J., Zhang, Z., Dong, Z., Shan, T. and Yin, Z. (2024) miR-150-5p Inhibits the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells by Targeting Irisin to Regulate the P38/MAPK Signaling Pathway. Journal of Orthopaedic Surgery and Research, 19, Article No. 190. [Google Scholar] [CrossRef] [PubMed]
[20] Guo, Y., Li, L., Gao, J., Chen, X. and Sang, Q. (2016) miR-214 Suppresses the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells and These Effects Are Mediated through the Inhibition of the JNK and P38 Pathways. International Journal of Molecular Medicine, 39, 71-80. [Google Scholar] [CrossRef] [PubMed]
[21] Zhu, Y., Wang, S., Ding, D., Xu, L. and Zhu, H. (2017) miR-217 Inhibits Osteogenic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells by Binding to Runx2. Molecular Medicine Reports, 15, 3271-3277. [Google Scholar] [CrossRef] [PubMed]
[22] Hu, N., Feng, C., Jiang, Y., Miao, Q. and Liu, H. (2015) Regulative Effect of miR-205 on Osteogenic Differentiation of Bone Mesenchymal Stem Cells (BMSCs): Possible Role of SATB2/Runx2 and ERK/MAPK Pathway. International Journal of Molecular Sciences, 16, 10491-10506. [Google Scholar] [CrossRef] [PubMed]
[23] Xu, J., Liu, X., Chen, J., Zacharek, A., Cui, X., Savant-Bhonsale, S., et al. (2009) Simvastatin Enhances Bone Marrow Stromal Cell Differentiation into Endothelial Cells via Notch Signaling Pathway. American Journal of Physiology-Cell Physiology, 296, C535-C543. [Google Scholar] [CrossRef] [PubMed]
[24] 齐磊. miR-34b对骨髓间充质干细胞成骨分化的影响及相关机制[J]. 临床与病理杂志, 2016, 36(7): 898-904.
[25] Chen, L., HolmstrØm, K., Qiu, W., Ditzel, N., Shi, K., Hokland, L., et al. (2014) MicroRNA-34a Inhibits Osteoblast Differentiation and in vivo Bone Formation of Human Stromal Stem Cells. Stem Cells, 32, 902-912. [Google Scholar] [CrossRef] [PubMed]
[26] Zhou, Y., Qiao, H., Liu, L., et al. (2021) miR-21 Regulates Osteogenic and Adipogenic Differentiation of BMSCs by Targeting PTEN. Musculoskelet Neuronal Interact, 1, 568-576.
[27] Zhao, C., Gu, Y., Wang, Y., Qin, Q., Wang, T., Huang, M., et al. (2021) miR-129-5p Promotes Osteogenic Differentiation of BMSCs and Bone Regeneration via Repressing Dkk3. Stem Cells International, 2021, Article ID: 7435605. [Google Scholar] [CrossRef] [PubMed]
[28] Lin, Z., He, H., Wang, M. and Liang, J. (2019) MicroRNA‐130a Controls Bone Marrow Mesenchymal Stem Cell Differentiation Towards the Osteoblastic and Adipogenic Fate. Cell Proliferation, 52, e12688. [Google Scholar] [CrossRef] [PubMed]
[29] Cao, W., Yang, X., Hu, X.H., Li, J., Tian, J., OuYang, R., et al. (2023) miR-344d-3p Regulates Osteogenic and Adipogenic Differentiation of Mouse Mandibular Bone Marrow Mesenchymal Stem Cells. PeerJ, 11, e14838. [Google Scholar] [CrossRef] [PubMed]
[30] Zhang, Z., Jiang, W., Hu, M., Gao, R. and Zhou, X. (2021) miR-486-3p Promotes Osteogenic Differentiation of BMSC by Targeting CTNNBIP1 and Activating the Wnt/β-Catenin Pathway. Biochemical and Biophysical Research Communications, 566, 59-66. [Google Scholar] [CrossRef] [PubMed]
[31] Zhang, L., Zhang, C., Zheng, J., Wang, Y., Wei, X., Yang, Y., et al. (2023) miR-155-5p/Bmal1 Modulates the Senescence and Osteogenic Differentiation of Mouse BMSCs through the Hippo Signaling Pathway. Stem Cell Reviews and Reports, 20, 554-567. [Google Scholar] [CrossRef] [PubMed]
[32] Tang, J., Lin, X., Zhong, J., Xu, F., Wu, F., Liao, X., et al. (2019) miR-124 Regulates the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells by Targeting Sp7. Molecular Medicine Reports, 19, 3807-3814. [Google Scholar] [CrossRef] [PubMed]
[33] Zhang, Y., Zhou, L., Zhang, Z., Ren, F., Chen, L. and Lan, Z. (2020) miR-10a-5p Inhibits Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells. Molecular Medicine Reports, 22, 135-144. [Google Scholar] [CrossRef] [PubMed]
[34] Jiang, K., Teng, G. and Chen, Y. (2020) MicroRNA‐23 Suppresses Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells by Targeting the MEF2C‐Mediated MAPK Signaling Pathway. The Journal of Gene Medicine, 22, e3216. [Google Scholar] [CrossRef] [PubMed]
[35] Yang, Q., Zhou, Y., Wang, T., Cai, P., Fu, W., Wang, J., et al. (2021) MiRNA‐1271‐5p Regulates Osteogenic Differentiation of Human Bone Marrow‐Derived Mesenchymal Stem Cells by Targeting Forkhead Box O1 (FOXO1). Cell Biology International, 45, 1468-1476. [Google Scholar] [CrossRef] [PubMed]